pause halt pause button
Biotech

FDA freezes enrollment in MacroGenics cancer trial after death

MacroGenics had already paused enrollment in the trial of bispecific antibody lorigerlimab after four patients experienced severe side effects.
Darren Incorvaia Feb 24, 2026 2:00pm
harbor at sunset

Harbour sails with Solstice in $1.1B biobucks deal

Feb 24, 2026 2:38pm
GettyImages-2217220002jpg

iRegene Dual Firsts: US Dosing in PD Phase IIa, China MSA Enrollment

Feb 23, 2026 8:00am
weight loss scale weigh measure tape obesity overweight

Novo's triple G candidate drives 20% weight loss in phase 2

Feb 24, 2026 7:42am
Anatomical model of human arm and torso showing muscle

Abcuro's KLRG1 antibody flunks phase 2/3 muscle disease study

Feb 24, 2026 9:15am
Fly fishing

Evinova reels in AI partnerships with Astellas and AZ deals

Feb 24, 2026 12:00pm
More News

Medtronic's diabetes business MiniMed eyes $784M IPO

Feb 24, 2026 9:35am

GSK explores frontiers of siRNA with $1B deal for 2 drugs

Feb 24, 2026 8:10am

New biotech Slate aims to solve migraine injection equation

Feb 24, 2026 7:30am

Fierce Biotech Fundraising Tracker '26: Slate; Altesa & more

Feb 24, 2026 7:30am